Literature DB >> 10549623

Live cell fluorescence imaging of T cell MEKK2: redistribution and activation in response to antigen stimulation of the T cell receptor.

B C Schaefer1, M F Ware, P Marrack, G R Fanger, J W Kappler, G L Johnson, C R Monks.   

Abstract

T cell activation requires engagement of the T cell receptor (TCR) at the interface of conjugates formed with antigen-presenting cells. TCR engagement is accompanied by a redistribution of specific signaling molecules to the cytoplasmic region of the TCR complex. In this study, immunocytochemistry and live cell fluorescence imaging demonstrate that T cell MEK kinase 2 (MEKK2) is translocated to the T cell/antigen-presenting cell interface in response to antigen activation. MEKK2 translocation occurs more rapidly as the antigen concentration is increased. Biochemical activation of MEKK2 follows TCR stimulation, and expression of a dominant-negative MEKK2 inhibits TCR-mediated conjugate stabilization and ERK and p38 MAP kinase phosphorylation. Live cell fluorescence imaging thus enables characterization of signal transducers that are dynamically translocated following TCR engagement.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10549623     DOI: 10.1016/s1074-7613(00)80116-8

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  24 in total

Review 1.  Regulation of T cell development in the thymus.

Authors:  J Kaye
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

Review 2.  Imaging T-cell antigen recognition and comparing immunological and neuronal synapses.

Authors:  E Donnadieu; P Revy; A Trautmann
Journal:  Immunology       Date:  2001-08       Impact factor: 7.397

3.  Transmodulation of BCR signaling by transduction-incompetent antigen receptors: implications for impaired signaling in anergic B cells.

Authors:  Barbara J Vilen; Kathy M Burke; Michelle Sleater; John C Cambier
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

Review 4.  Two-photon tissue imaging: seeing the immune system in a fresh light.

Authors:  Michael D Cahalan; Ian Parker; Sindy H Wei; Mark J Miller
Journal:  Nat Rev Immunol       Date:  2002-11       Impact factor: 53.106

5.  Complex and dynamic redistribution of NF-kappaB signaling intermediates in response to T cell receptor stimulation.

Authors:  Brian C Schaefer; John W Kappler; Abraham Kupfer; Philippa Marrack
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-14       Impact factor: 11.205

6.  MEKK3 is essential for lipopolysaccharide-induced interleukin-6 and granulocyte-macrophage colony-stimulating factor production in macrophages.

Authors:  Kihwan Kim; Omar Duramad; Xiao-Feng Qin; Bing Su
Journal:  Immunology       Date:  2006-11-20       Impact factor: 7.397

7.  Identification of MEKK2/3 serine phosphorylation site targeted by the Toll-like receptor and stress pathways.

Authors:  Dongyu Zhang; Valeria Facchinetti; Xiaofang Wang; Qiaojia Huang; Jun Qin; Bing Su
Journal:  EMBO J       Date:  2005-12-15       Impact factor: 11.598

8.  MEK kinase 2 and the adaptor protein Lad regulate extracellular signal-regulated kinase 5 activation by epidermal growth factor via Src.

Authors:  Weiyong Sun; Xudong Wei; Kamala Kesavan; Timothy P Garrington; Ruihua Fan; Junjie Mei; Steven M Anderson; Erwin W Gelfand; Gary L Johnson
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

9.  Restoration of miR17/20a in solid tumor cells enhances the natural killer cell antitumor activity by targeting Mekk2.

Authors:  Hong Jiang; Ping Wang; Xiaohua Li; Qilong Wang; Zhong-Bin Deng; Xiaoying Zhuang; Jingyao Mu; Lifeng Zhang; Baomei Wang; Jun Yan; Donald Miller; Huang-Ge Zhang
Journal:  Cancer Immunol Res       Date:  2014-05-06       Impact factor: 11.151

10.  Disruption of Mekk2 in mice reveals an unexpected role for MEKK2 in modulating T-cell receptor signal transduction.

Authors:  Zijian Guo; Gavin Clydesdale; Jinke Cheng; Kihwan Kim; Lin Gan; David J McConkey; Stephen E Ullrich; Yuan Zhuang; Bing Su
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.